In this episode of ASTCT Talks, supported by an educational grant from Sanofi US, host Dr. Corey Cutler, MD, from Dana-Farber Cancer Institute, sits down with Dr. Sanjeet Singh Dadwal, MD, chief of infectious diseases at City of Hope, to explore a critical aspect of chronic graft-versus-host disease (GVHD): immune dysfunction and infection risk.

The discussion highlights:

• How chronic GVHD independently contributes to immune deficits and infection susceptibility.

• Infectious risks associated with FDA-approved therapies for chronic GVHD.

• Common infections in this population and why vigilance matters.

• Practical guidance on prophylaxis strategies, vaccination timing, and navigating real-world challenges like food safety.

This episode offers actionable insights for clinicians managing infection prevention and survivorship care in patients with chronic GVHD.

Read “Infectious Disease Considerations in Chronic Graft-versus-Host Disease and Transplantation Survivors,” included in the 2024 GVHD Supplement collection published by Transplantation and Cellular Therapy.